Actively Recruiting
Evaluating Baroreflex Activation Therapy Using the Barostim System Compared to Usual Care in Adults with Heart Failure
Led by CVRx, Inc. · Updated on 2026-11-03
2500
Participants Needed
21
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating Baroreflex Activation Therapy BAT using the Barostim System in adults with heart failure classified as NYHA Functional Class II or III, with reduced heart function LVEF under 50% and specific blood marker levels NT-proBNP under 5,000 pgmL despite receiving usual guideline-directed medical therapies. The study aims to assess the safety and effectiveness of adding the Barostim System to usual care compared to usual care alone, particularly focusing on reducing all-cause mortality and heart failure-related events like cardiac transplant or worsening heart failure. Participants are randomly assigned to either receive the Barostim System device implant plus usual care or continue with usual care medical management without the device. The study follows participants with these two groups in parallel, monitoring outcomes for up to 24 months after treatment begins. The Barostim System delivers BAT via an implanted device, and the study includes safety monitoring within 180 days post-implant. Throughout the study, participants undergo various assessments including quality of life evaluations, six-minute hall walk tests, laboratory tests for NT-proBNP levels, and tracking of hospitalizations and mortality over 24 months. These measurements help researchers understand the impact of the therapy on heart failure symptoms and patient well-being. Participants must comply with medication management and follow-up visits as required, while safety and effectiveness endpoints are carefully monitored by the research team.
CONDITIONS
Brief Title
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Research Team
C
Christina Dierkhising
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here